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By ammonium sulphate precipitation, phosphocellulose and DEAE-Sephacel chromatography and 
Sephadex G-75 gel filtration, a factor was separated from rat liver cytosol which was shown to suppress 
the inhibitory effect of the steroid deoxycorticosterone (DOC) on the specific [3H]glucocorticoid binding 
to cytoplasmic receptors. By SDS-polyacrylamide gel electrophoresis (SDS-PAGE) of factor-containing 
fractions its M, was suggested to be about 40000. The possible role of this factor in the regulation of 
glucocorticoid receptor apparatus function is discussed. 
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1. INTRODUCTION 
Cytoplasmic glucocorticoid receptors from 
various tissues and organs are quite similar in a 
number of physical and chemical characteristics. 
Nevertheless, tissue specificity was indicated in 
their interaction with some steroids [l]. For exam- 
ple, there is a significant difference in the ability of 
steroid DOC to suppress specific binding of 
[3H]glucocorticoids to liver and heart cytosols [2]. 
Liver cytosol was reported to contain a protein 
fraction which decreases sensitivity of the heart 
glucocorticoid receptor system to DOC [3]. We 
here present data on the separation of a receptor- 
modifying factor (RMF) from glucocorticoid 
receptors in liver cytosol and its partial purifica- 
tion by chromatography and gel filtration. 
2. MATERIALS AND METHODS 
Intact and adrenalectomized Wistar rats were 
used and maintained as described previously [4]. 
[3H]Triamcinolone acetonide ([3H]TA) (spec. act. 
29 Ci/mmol) was purchased from Amersham 
(England), DEAE-Sephacel and Sephadex G-75 
from Pharmacia (Sweden), and electrophoresis 
Glucocorticoid Glucocorticoid receptor 
reagents were from Bio-Rad (USA). All other 
chemicals used were of A-grade purity. 
To estimate [3H]glucocorticoid receptor binding 
liver and heart cytosols were prepared from 
adrenalectomized rats as in [4] using buffer solu- 
tion A [20 mM Tris, 1 mM EDTA, 2 mM 
dithiothreitol (DTT), 10% (w/v) glycerol, 30 mM 
KC1 (pH 7.4)] at 4°C. Precipitation by (NH&S04 
of liver glucocorticoid receptors was performed in 
buffer B (buffer A containing additionally 5 mM 
DTT and 10 mM NazMoO4). [‘HITA specific 
binding to cytosol preparations was estimated as in 
[4]. To separate and purify RMF, liver cytosol 
from intact rats was prepared using buffer C 
(20 mM Tris, 1 mM EDTA, 30 mM KC1 (pH 7.4)] 
at 4°C. 
To test liver cytosol fractions for the presence of 
RMF activity 0.15 ml of the liver fraction was 
added to 0.15 ml of adrenalectomized rat heart 
cytosol (protein concentration S-10 mg/ml) and 
specific [3H]TA binding was estimated in the 
presence of 20-fold excess (10m6 M) unlabeled 
DOC. That quantity of RMF which increased 
specific [3H]TA binding by heart cytosol in the 
presence of DOC to the value of 1 pmol was arbi- 
trarily taken as one unit of RMF activity. From the 
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fractions obtained after different steps of purifica- 
tion proteins were precipitated by 10% trichloro- 
acetic acid. Fifty pg of proteins precipitated were 
analyzed on 10% SDS-PAGE as in 151. Protein 
was determined according to [6] as modified in [7]. 
Radiometry was carried out on an LKB-1215 
Rackbeta scintillation spectrometer with a 3H 
counting efficiency of 40%. 
3. RESULTS AND DISCUSSION 
Fig. 1,2 show suppression of specific [3H]TA 
binding to glucocorticoid receptors of heart and 
liver cytosols by 20-fold excess unlabeled DOC. 
The suppressive ffect of DOC was weak in the 
non-fractionated liver cytosol (fig.Ia) but in- 
creased greatly after fractionation of liver gluco- 
corticoid receptors by precipitation at O-30070 
(NH&S04 saturation as in [S] (fig.lb). Recom- 
bination of the glucocorticoid receptor fraction 
~~30~0 pre~ipitable fraction) with the 50-70~0 
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Fig. 1. Specific [3H]TA binding to glucocorticoid 
receptors in non-fractionated and fractionated liver 
cytosol in the presence of 20-fold excess unlabeled DOC. 
(a) Binding of 13H]TA (5 x IO-’ M) to non-fractionated 
liver cytosol in the presence of DOC (lOA M). (b) 
13H]TA specific binding to the O-30% (NH&SO.+-pre- 
cipitable fraction in the presence of DOC. (c) The same 
as in b but after the addition of the SO-70% 
(NH&S04-precipitable fraction. Values are means + SE 
of 4 independent measurements. 
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Fig.2. Suppression by DOC of [‘HITA specific binding 
to heart cytosol glucocorticoid receptors in the absence 
or presence of the 50-70% (N~)2SO4-precipitable 
fraction from liver cytosol. (a) t3H]TA (5 x lo-* M) 
binding to heart cytosol in the absence of DOC. (b) The 
same as in a but in the presence of DOC (10m6 M). (c) 
The same as in b but in the presence of the 50-70070 
(NH&S04-precipitable fraction from liver. (d) The 
same as in c but the 50-70% (NH&S04-precipitable 
fraction was treated with 1 pg/Atso trypsin for 15 min at 
lO”C, and soybean trypsin inhibitor (IO-fold excess) 
before addition to heart cytosol. Values are means + SE 
of 6 independent measurements. 
~~)2SO~-pr~ipitable fraction from the same 
liver cytosol again made the glucocorticoid recep- 
tor system less sensitive to DOC (fig.lc). Fig.2a 
shows that 20-fold excess unlabeled DOC sharply 
suppressed specific t3H]TA binding to non- 
fractionated heart cytosol. The sensitivity of the 
heart glucocorticoid receptor system to DOC 
sig~fic~tly decreased after the addition of the 
50-70% (NH&S04-precipitable fraction from 
liver cytosol (fig.2b). After preliminary treatment 
of this fraction with trypsin its ability to influence 
the DOC effect was lost (fig.2c). The data obtained 
show that the 50--70% ~~)2SO4-precipitable 
fraction from liver cytosol contains a protein fac- 
tor which is able to affect the interaction of 
steroids with glucocorticoid receptors. We call it 
RMF. 
Table 1 presents data on a stepwise fractionation 
of cytosol [obtained from livers (197 g wet wt) of 
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Volume 171, number 1 FEBS LETTERS June 1984 
Table 1 
Steps of liver cytosol RMF purification 
Step Volume Total proteins Total activity Purification 
(ml) (mg) (relative units)= factorb 
Cytosol 300 7140 406.98 - 
SO-70% (NH&S04 77 2009 372.44 3.25 
Breakthrough from PC-column 85 1854 351.13 3.32 
DEAE-Sephacel 
chromatography (0.06 M) 25 8.3 242.56 512.70 
* See section 2 
b Ratio of RMF activity/mg fraction protein to RMF activity/mg non-fractionated cytosol protein 
Yield 
(%) 
100 
91.5 
86.3 
59.6 
intact rats] performed for the characterization and complexes which were absorbed on the column. 
partial purification of RMF. At the step of RMF The breakthrough fraction contained up to 86% of 
precipitation at 50-70% saturation by (NH&S04 initial RMF activity (table 1). It was collected, ap- 
the loss of its activity was not more than 15% plied to a DEAE-Sephacel column (5.0 cm2 x 
(table 1) and a 3.25fold enrichment of RMF ac- 10 cm) equilibrated with buffer C and the ab- 
tivity relative to protein content was achieved. The sorbed proteins were eluted by a linear KC1 gra- 
50-70% (NH.&S04-precipitable fraction was dient (60 ml 30 mM KCl-60 ml 300 mM KCl). As 
dissolved in buffer C and dialyzed twice against he can be seen from fig.3, maximal RMF activity was 
same buffer (1: 50, v/v). It was then applied to a found at 0.06 M KC1 in the eluate. RMF-con- 
phosphocellulose P-II column (2.0 cm2 x 15 cm) taming fractions were collected, lyophilized and 
and eluted with buffer C. This permitted separa- used for further investigations. At this step of 
tion of RMF activity from positively charged pro- purification the loss of RMF activity was about 
teins including activated glucocorticoid-receptor 40% (table 1). 
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Fig.3. DEAE-Sephacel chromatography of phospho- 
cellulose breakthrough fraction (liver cytosol). 
Lyophilized preparations of RMF were dis- 
solved in buffer C to a final protein concentration 
of 3-5 mg/ml. Samples (1 ml) were applied to a 
Sephadex G-75 column (10 cm2 x 60 cm) and 
eluted with buffer C. The Stokes radius (R,) of 
RMF was estimated by linear regression of R, from 
the K,, of protein standards [9] listed in the legend 
to fig.4. The fraction corresponding to an R, of 
31.25 A was analyzed on the SDS-PAGE in 
parallel with the samples obtained after earlier 
steps of purification. In preliminary experiments 
we found that on gel filtration of the 50-70% 
(NH&S04-precipitable fraction on Sephadex G-75 
(at about 20 mg/ml protein) the maximal RMF ac- 
tivity was eluted in samples corresponding to R, 
31.25 + 3.75 A or roughly to M, 40000 (fig.4). 
SDS-PAGE patterns (fig.5) show that one band 
corresponding to M, 40000 is absent in the 
DEAE-Sephacel breakthrough samples where 
RMF activity was also not detected. This band is 
also present in samples of the third (DEAE- 
Sephacel) and fourth (Sephadex G-75) purification 
steps. The last two samples also reveal a band cor- 
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Fig.4. Gel filtration on Sephadex G-75 of the 50-70% 
~~4)zS~$-prec~pitab~e fraction (liver cytosol). Arrows 
denote elutian positions of protein standards: (I) BSA, 
(2) ovalbumin, (3) chymotrypsinogen, (4) myoglobin, (5) 
cytochrome c. Volume of elution probes is 1.86 ml. 
Representative results of ane out of 3 separate 
experiments. 
c d a 
Fig,T, SDS-PAGE patterns of samples obtained after 
various steps of liver RMF purification. (a) 
DEAE-Sephacel breakthrough fraction, (b) DEAE- 
Sephacel chromatography step fraction (eluted at 
0.06 M KC1), (c) 31 A Sephadex G-75 fraction (4th step 
of purification), (d) protein standards. 
responcling to A4, 14000. We cannot exclude the 
possibility that the latter appears as a result of 
splitting of native RMF during the preparation of 
samples for electrophoresis, Other data indirectly 
support the notion that the band with 1M, -4OooO 
corresponds to RMF. Electrophoresis of the third- 
purification-step samples from kidney, lung, 
skeletal muscle and heart cytosols did not reveal 
this band (figfiJi). Also, we were not able to detect 
any RMF activity in cytosoi fractions from these 
organs (not sho~nj. 
These data show that the differences in 
glucocorticoid receptor sensitivity to DOC in 
various organs can be due to the presence, absence 
or different concentrations of protein factor (IK 
~~~ dissimilar to steroidophilic components of 
receptor apparatus. We cannot rule out that the 
factor described is a non-steroidophilic regulatory 
subunit of glucocorticoid receptors. However, this 
suggestion requires further experimental support. 
It is also necessary to elucidate whether there are 
any relations between RMF and high-mofecular- 
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FigEi. SDS-PAGE patterns of samples obtained after 
3-step fractionations (last step: DEAE-Sephacel) of 
various cytosols: (a) Lung, (b) skeletal muscle, (c) heart, 
(d) kidney, (e) liver, (f) protein standards. 
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mass modulators of glucocorticoid receptor com- 
plex activation which were described recently 
[lO,ll]. 
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